Tramadol Added to 1.5% Mepivacaine for Axillary Brachial Plexus Block Improves Postoperative Analgesia Dose-Dependently
Authors:
- Cornelia BluntCBCornelia Blunt
- Eric VielEVEric Viel
- Philippe CuvillonPCPhilippe Cuvillon
- Philippe NouguierPNPhilippe Nouguier
- Gilles DautelGDGilles Dautel
- Sylvie BoileauSBSylvie Boileau
- Florence GirardFGFlorence Girard
- Hervé BouazizHBHervé Bouaziz
- 1 April 2004
- journal article
- clinical trial
- Published by Wolters Kluwer Health in Anesthesia & Analgesia
- Vol. 98 (4) , 1172-1177
Abstract
Adjuncts to local anesthetics for peripheral plexus blockade may enhance the quality and duration of anesthesia and postoperative analgesia. The analgesic, tramadol, has a unique mechanism of action that suggests efficacy as such an adjunct. It displays a central analgesic and peripheral local anesthetic effect. We designed a prospective, randomized, controlled and double-blind clinical trial to assess the effect of tramadol added to brachial plexus anesthesia. One-hundred patients scheduled for carpal tunnel release surgery under brachial plexus anesthesia were randomized into four groups. All patients received 1.5% mepivacaine 40 mL plus a study solution containing either isotonic sodium chloride (Group P, n = 17), tramadol 40 mg (Group T40, n = 22), tramadol 100 mg (Group T100, n = 20) or tramadol 200 mg (Group T200, n = 20). We evaluated the time of onset of anesthesia, duration of sensory and motor blockade, duration and quality of postoperative analgesia, and occurrence of adverse effects. Onset and duration of sensory and motor blocks were not different among groups. The number of patients requesting analgesia in the postoperative period was significantly less in the 3 tramadol groups compared with the placebo group (P = 0.02); this was also noted with the placebo and T40 groups compared with the T200 group. No statistical significance was demonstrated between the placebo and the T40 group or the T100 group and the T200 group. Furthermore, there was a significant trend effect among groups applying the Cochran-Armitage tendency test (P = 0.003), suggesting a dose-dependent decrease for additional postoperative analgesia requirements when tramadol was added. Side effects did not differ among groups, although they were more frequently recorded in the T groups. Our study suggests that tramadol added to 1.5% mepivacaine for brachial plexus block enhances in a dose-dependent manner the duration of analgesia with acceptable side effects. However, the safety of tramadol has to be investigated before allowing its use in clinical practice.Keywords
This publication has 18 references indexed in Scilit:
- Tramadol—Present and FutureAnaesthesia and Intensive Care, 2000
- Epidural tramadol for postoperative pain after Cesarean sectionCanadian Journal of Anesthesia/Journal canadien d'anesthésie, 1999
- Preoperative adjuvant epidural tramadol: the effect of different doses on postoperative analgesia and pain processingActa Anaesthesiologica Scandinavica, 1998
- The addition of opioids to local anaesthetics in brachial plexus block: the comparative effects of morphine, buprenorphine and sufentanilAnaesthesia, 1997
- Dose-Range Effects of Clonidine Added to Lidocaine for Brachial Plexus BlockAnesthesiology, 1997
- Effets du CO2 et de l'adrénaline sur la lidocaïne 1 % dans le bloc axillaireAnnales Françaises d'Anesthésie et de Réanimation, 1997
- The Place of Tramadol in the Therapy of PainDrugs, 1997
- Tolérance et sécurité dʼemploi du tramadolDrugs, 1997
- Le tramadol dans les douleurs aiguësDrugs, 1997
- Pharmacologie du tramadolDrugs, 1997